A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
Completed · Phase 1
Conditions studied: Healthy
In brief
The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.
Key facts
- Study ID
- NCT07044479
- Run by
- Merck Sharp & Dohme LLC
- People needed
- 60
- Starts
- 2025-07-03
- Expected to finish
- 2025-08-28
- Last updated by the study team
- 2025-09-03
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- The key inclusion criteria include but are not limited to the following:
- Is in good health
- Is a non-smoker for at least 3 months prior to study entry
- Part 1 only: Consumes at least 1 cup of caffeinated coffee per day
- Part 2 only: Consumes at least 1 cup of caffeinated tea per day
You may not qualify if…
- The key exclusion criteria include but are not limited to the following:
- Has a history or presence of clinically significant medical or psychiatric condition or disease
- History of gastrointestinal disease which might affect food and drug absorption, or has had gastric bypass or similar surgery.
Where it is running
- Celerion, Inc. ( Site 0001) — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.